Insights and updates for pharmaceutical companies
Jinfo Blog
15th August 2017
Abstract
Find out what Jinfo offers Subscribers in biopharma, life sciences and the STM field.
Item
Mergers and acquisitions, major drug patent expiries and an average drug development time of 10 to 15 years are leading to shrinking information centres and increased expectation of end user research.
However, conversely, current awareness and specialised industry research is the cornerstone of new drug development, potentially helping to drastically reduce the cost of drug development and its speed to market.
If information teams can redefine themselves as experts at the more complex and strategic end of their organisations' research needs they should be assured of their place for many years to come.
What is it that pharma info teams get from Jinfo?
Jinfo's customers in the pharmaceutical, life sciences and STM sectors benefit from access to specific coverage of sources and technology products directly related to areas such as discovery, patents, visualisation tools and pharma content products.
On top of that is the value piece - access to strategic articles and reports helping those responsible for managing and developing information services to take their teams forward. This includes our recent original research where we shed unique light on information services and provided the data, analysis and models to empower our customers to benchmark their own services against a competitor set.
Here's just a sample of the original research, market landscapes, product reviews and articles available to Jinfo Subscribers:
- Jinfo survey - exploring discovery services - 2017
- Benchmark information services - optimise your structure
- Market landscape - patent products
- Product review of PharmaCircle Business Class Professional
- Revolutionising big pharma with big data, visualisation and analytics
Find out more in our free pharma-focused events this month:
Content
Join a pharma-focused walkthrough of Jinfo, including a short presentation on our benchmarking research and how you can use it now to lay the groundwork for 2018. We'll also highlight our articles, reports and webinars of interest to organisations in the pharmaceutical sector in areas from specialist content sources to patent databases and our research into discovery solutions.
This event is open to Jinfo customers and prospects: Monday 21st August, 16:00 - 16:30 (BST)
Request more information and register by contacting Catherine Dhanjal, head of content, catherine.dhanjal@jinfo.com
Community
Some of the best insights come from peers. Join us at an upcoming Community session - the BioPharma Roundtable - and experience for yourself the special value of these private, confidential sessions.
This event is open to Jinfo customers at any level of subscription: Wednesday 23rd August, 16:00 - 17:00 (BST)
Request more information and register by contacting Amy Burns, head of community, amy.burns@jinfo.com
Consulting
Jinfo works with a number of pharma companies to consult on department optimisation, strategic planning, and stakeholder engagement. To learn more, contact Robin Neidorf, director of research and head of consulting, robin.neidorf@jinfo.com
- Blog post title: Insights and updates for pharmaceutical companies
- Link to this page
- View printable version
- Research update - creating an even better Jinfo Community
Thursday, 10th August 2017 - Jinfo for optimising your research service
Wednesday, 2nd August 2017 - My Favourite Tipples from a pharma information centre manager
Wednesday, 14th December 2016
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 12th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024